$2.38
-0.06[-2.46%]
At close: Apr 25
$2.38
0[0.00%]
After Hours: 6:14PM EDT
OncoCyte
(NASDAQ:OCX)Latest News for OncoCyte Stock (NASDAQ:OCX)
OncoCyte Stock (NASDAQ: OCX)
Categories: All
Wednesday, April 24, 2024
Tuesday, April 23, 2024
Monday, April 22, 2024
Wednesday, April 17, 2024
Monday, April 15, 2024
- Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 15, 2024, 2:11PM
- Benchmark Reiterates Speculative Buy on OncoCyte, Maintains $5 Price TargetBenzinga Newsdesk - Apr 15, 2024, 11:09AM
- Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 15, 2024, 5:45AM
Friday, April 12, 2024
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga Insights - Apr 12, 2024, 4:31PM
- Oncocyte shares are trading higher after the company announced a transplant assay partnership agreement with Bio-Rad laboratoriesBenzinga Newsdesk - Apr 12, 2024, 9:22AM
- Top 3 Health Care Stocks That May Collapse In Q2Avi Kapoor - Apr 12, 2024, 8:34AM
- Earnings Scheduled For April 12, 2024Benzinga Insights - Apr 12, 2024, 7:17AM
- OncoCyte Q4 EPS $(2.18) Misses $(1.14) Estimate, Sales $314.00K Miss $316.67K EstimateBenzinga Newsdesk - Apr 12, 2024, 6:07AM
- Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 12, 2024, 5:32AM
- Reported Earlier, Oncocyte Prices $15.8M Private Placement Of Securities Priced At-The-Market Under Nasdaq RulesBenzinga Newsdesk - Apr 12, 2024, 2:48AM
Thursday, April 11, 2024
Wednesday, December 06, 2023
Monday, November 13, 2023
Thursday, November 09, 2023
- Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 9, 2023, 1:13PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Nov 9, 2023, 12:31PM
- Needham Maintains Buy on OncoCyte, Lowers Price Target to $3.6Benzinga Newsdesk - Nov 9, 2023, 11:43AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Nov 9, 2023, 8:06AM
- OncoCyte Q3 Sales $429.00K Beat $330.00K Estimate, Q3 Net Consolidated Operating Loss Was $6.5M Compared To $1.7M YoYBenzinga Newsdesk - Nov 9, 2023, 7:25AM
- Earnings Scheduled For November 9, 2023Benzinga Insights - Nov 9, 2023, 6:52AM
Wednesday, November 08, 2023
Wednesday, October 25, 2023
Tuesday, October 03, 2023
Friday, September 15, 2023
Monday, August 28, 2023
Thursday, August 24, 2023
Tuesday, August 15, 2023
Monday, August 14, 2023
Thursday, August 10, 2023
- Needham Maintains Buy on OncoCyte, Lowers Price Target to $4.25Benzinga Newsdesk - Aug 10, 2023, 11:53AM
- CORRECTION: OncoCyte Q2 Adj. EPS $(0.59) Beats $(0.87) Estimate, Sales $463.00K Beat $360.00K EstimateBenzinga Newsdesk - Aug 10, 2023, 7:34AM
- OncoCyte Q2 Adj. EPS $(0.59) Beats $(0.87) Estimate, Sales $463.00K Beat $360.00K EstimateBenzinga Newsdesk - Aug 10, 2023, 7:04AM
- Earnings Scheduled For August 10, 2023Benzinga Insights - Aug 10, 2023, 6:59AM
Wednesday, August 09, 2023
Tuesday, August 08, 2023
Monday, July 24, 2023
Tuesday, June 27, 2023
Thursday, May 11, 2023
Thursday, April 13, 2023
- Oncocyte's Announces Another Round Of Layoffs Leaving 20% Of Staff ImpactedVandana Singh - Apr 13, 2023, 10:05AM
- Reported Late Wednesday April 12, Oncocyte Corporation Announces A Reduction In Force Involving ~20% Of Its Workforce, Which Management Believes Will Extend Oncocyte's Cash Runway In 2024Happy Mohamed - Apr 13, 2023, 1:03AM